Pfizer Halts Tanezumab Studies For Back Pain , Diabetes Wall Street Journal Pfizer Inc. (PFE) has suspended studies of its drug tanezumab for treating chronic low back pain and nerve damage caused by diabetes at the request of the ... Pfizer halts tanezumab studies on FDA request MarketWatch Pfizer halts third study of experimental pain drug The Associated Press Pfizer Suspends Chronic Pain Studies In Tanezumab Clinical Trial Program .. Read more »